Abstract
The biotechnological relevance of protein glycosylation has exponentially grown in recent years. With the advances in protein glycosylation research, new possibilities for glyco-engineering have arisen, and a wide array of glycans can be designed and potentially transferred to target proteins in the biotechnologically relevant host Escherichia coli. Here we provide insight on how to select the best strains and plasmids. We also describe methods for determination of glycan expression and assembly, protein glycosylation using western blot, and preparation of samples for mass spectrometry.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Wacker M, Linton D, Hitchen PG et al (2002) N-linked glycosylation in Campylobacter jejuni and its functional transfer into E. coli. Science 298:1790–1793
Ciocchini AE, Rey Serantes DA, Melli LJ et al (2013) Development and validation of a novel diagnostic test for human brucellosis using a glyco-engineered antigen coupled to magnetic beads. PLoS Negl Trop Dis 7:e2048
Wacker M, Wang L, Kowarik M et al (2014) Prevention of Staphylococcus aureus infections by glycoprotein vaccines synthesized in Escherichia coli. J Infect Dis 209:1551–1561
Cuccui J, Thomas RM, Moule MG et al (2013) Exploitation of bacterial N-linked glycosylation to develop a novel recombinant glycoconjugate vaccine against Francisella tularensis. Open Biol 3:130002
Macmillan D, Bill RM, Sage KA et al (2001) Selective in vitro glycosylation of recombinant proteins: semi-synthesis of novel homogeneous glycoforms of human erythropoietin. Chem Biol 8:133–145
Durocher Y, Butler M (2009) Expression systems for therapeutic glycoprotein production. Curr Opin Biotechnol 20:700–707
Ihssen J, Kowarik M, Dilettoso S et al (2010) Production of glycoprotein vaccines in Escherichia coli. Microb Cell Fact 9:61
Iwashkiw JA, Fentabil MA, Faridmoayer A et al (2012) Exploiting the Campylobacter jejuni protein glycosylation system for glycoengineering vaccines and diagnostic tools directed against brucellosis. Microb Cell Fact 11:13
Hug I, Zheng B, Reiz B et al (2011) Exploiting bacterial glycosylation machineries for the synthesis of a Lewis antigen-containing glycoprotein. J Biol Chem 286:37887–37894
Valderrama-Rincon JD, Fisher AC, Merritt JH et al (2012) An engineered eukaryotic protein glycosylation pathway in Escherichia coli. Nat Chem Biol 8:434–436
Young NM, Brisson JR, Kelly J et al (2002) Structure of the N-linked glycan present on multiple glycoproteins in the Gram-negative bacterium, Campylobacter jejuni. J Biol Chem 277:42530–42539
Ielmini MV, Feldman MF (2011) Desulfovibrio desulfuricans PglB homolog possesses oligosaccharyltransferase activity with relaxed glycan specificity and distinct protein acceptor sequence requirements. Glycobiology 21:734–742
Nita-Lazar M, Wacker M, Schegg B et al (2005) The N-X-S/T consensus sequence is required but not sufficient for bacterial N-linked protein glycosylation. Glycobiology 15:361–367
Faridmoayer A, Fentabil MA, Mills DC et al (2007) Functional characterization of bacterial oligosaccharyltransferases involved in O-linked protein glycosylation. J Bacteriol 189:8088–8098
Schulz BL, Jen FE, Power PM et al (2013) Identification of bacterial protein O-oligosaccharyltransferases and their glycoprotein substrates. PLoS One 8:e62768
Vik A, Aas FE, Anonsen JH et al (2009) Broad spectrum O-linked protein glycosylation in the human pathogen Neisseria gonorrhoeae. Proc Natl Acad Sci U S A 106:4447–4452
Kowarik M, Young NM, Numao S et al (2006) Definition of the bacterial N-glycosylation site consensus sequence. EMBO J 25:1957–1966
Chen MM, Glover KJ, Imperiali B (2007) From peptide to protein: comparative analysis of the substrate specificity of N-linked glycosylation in C. jejuni. Biochemistry 46:5579–5585
Faridmoayer A, Fentabil MA, Haurat MF et al (2008) Extreme substrate promiscuity of the Neisseria oligosaccharyl transferase involved in protein O-glycosylation. J Biol Chem 283:34596–34604
Coimbra RS, Grimont F, Lenormand P et al (2000) Identification of Escherichia coli O-serogroups by restriction of the amplified O-antigen gene cluster (rfb-RFLP). Res Microbiol 151:639–654
Dykxhoorn DM, St Pierre R, Linn T (1996) A set of compatible tac promoter expression vectors. Gene 177:133–136
Lees-Miller RG, Iwashkiw JA, Scott NE et al (2013) A common pathway for O-linked protein-glycosylation and synthesis of capsule in Acinetobacter baumannii. Mol Microbiol 89:816–830
Paton AW, Paton JC (1999) Molecular characterization of the locus encoding biosynthesis of the lipopolysaccharide O-antigen of Escherichia coli serotype O113. Infect Immun 67:5930–5937
Rush JS, Alaimo C, Robbiani R et al (2010) A novel epimerase that converts GlcNAc-P-P-undecaprenol to GalNAc-P-P-undecaprenol in Escherichia coli O157. J Biol Chem 285:1671–1680
Aranda J, Poza M, Pardo BG et al (2010) A rapid and simple method for constructing stable mutants of Acinetobacter baumannii. BMC Microbiol 10:279
Friedman AM, Long SR, Brown SE et al (1982) Construction of a broad host range cosmid cloning vector and its use in the genetic analysis of Rhizobium mutants. Gene 18:289–296
Wang RF, Kushner SR (1991) Construction of versatile low-copy-number vectors for cloning, sequencing and gene expression in Escherichia coli. Gene 100:195–199
Linton D, Dorrell N, Hitchen PG et al (2005) Functional analysis of the Campylobacter jejuni N-linked protein glycosylation pathway. Mol Microbiol 55:1695–1703
Durfee T, Nelson R, Baldwin S et al (2008) The complete genome sequence of Escherichia coli DH10B: insights into the biology of a laboratory workhorse. J Bacteriol 190:2597–2606
Tsai CMFC (1982) A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Anal Biochem 119:115–119
Garcia-Quintanilla F, Iwashkiw JA, Price NL et al (2014) Production of a recombinant vaccine candidate against Burkholderia pseudomallei exploiting the bacterial N-glycosylation machinery. Front Microbiol 5:381
Shevchenko A, Jensen ON, Podtelejnikov AV et al (1996) Linking genome and proteome by mass spectrometry: large-scale identification of yeast proteins from two dimensional gels. Proc Natl Acad Sci U S A 93:14440–14445
Scott NE, Parker BL, Connolly AM et al (2011) Simultaneous glycan-peptide characterization using hydrophilic interaction chromatography and parallel fragmentation by CID, higher energy collisional dissociation, and electron transfer dissociation MS applied to the N-linked glycoproteome of Campylobacter jejuni. Mol Cell Proteomics 10:M000031–MCP201
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this protocol
Cite this protocol
Vozza, N.F., Feldman, M.F. (2015). Glyco-engineering O-Antigen-Based Vaccines and Diagnostics in E. coli . In: Castilho, A. (eds) Glyco-Engineering. Methods in Molecular Biology, vol 1321. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-2760-9_5
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2760-9_5
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-2759-3
Online ISBN: 978-1-4939-2760-9
eBook Packages: Springer Protocols